NASDAQ:LMNS Lumenis (LMNS) Stock Price, News & Analysis → The #1 Opportunity of the decade? (From Behind the Markets) (Ad) Free LMNS Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Lumenis alerts: Email Address Ad DTIBiden’s $374B Giveaway Into This SectorBiden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right hereClick here for the full story About Lumenis Stock (NASDAQ:LMNS)Lumenis Ltd. (Lumenis) is a provider of energy-based, minimally invasive clinical solutions. The Company operates through three segments: surgical, ophthalmic and aesthetic. The Company offers energy-based solutions for medically necessary and elective procedures, primarily for the aging population. Its solutions include the holmium laser, the Lumenis Pulse 120H, used for urologic applications; the VersaPulse PowerSuite platform which uses holmium lasers for urologic applications; the M22 multi-energy, a multi-application platform for the treatment of various skin conditions, and the Selecta multi-modality platform for retinal, secondary cataract and glaucoma therapies. It offers products to hospitals, outpatient clinics, ambulatory surgery centers, physicians' offices, private clinics and aesthetic chains. Its locations include Yokneam, Israel, where surgical and aesthetic products are manufactured, and Salt Lake City, Utah, where ophthalmic products are manufactured.Read More Ad DTIBiden’s $374B Giveaway Into This SectorBiden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right hereClick here for the full story LMNS Stock News HeadlinesNo headlines for this company have been tracked by MarketBeat.com Receive LMNS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Lumenis and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/12/2015Today4/19/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNASDAQ:LMNS CUSIPN/A CIK1004945 Webwww.lumenis.com Phone+972-4-9599000FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesHarel Beit-On (Age 52)Chairman of the Board Zipora Ozer-Armon (Age 51)Chief Executive Officer Ophir YakovianChief Financial OfficerQiying ZhaiSenior Vice President and Regional President, Lumenis ChinaEran Cohen (Age 57)Vice President - Global Operations Elad BenjaminVice President and General Manager - Surgical Strategic Business UnitHadas PadanVice President and General Manager Vision Strategic Business UnitRoy RamatiVice President, General Manager - Aesthetic Strategic Business UnitKfir AzoulayVice President - Corporate MarketingIdo Ben-TovVice President - ServiceMore Executives LMNS Stock Analysis - Frequently Asked Questions How were Lumenis' earnings last quarter? Lumenis Ltd. (NASDAQ:LMNS) issued its earnings results on Tuesday, May, 12th. The medical equipment provider reported $0.06 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.11 by $0.05. The medical equipment provider earned $68.51 million during the quarter, compared to analysts' expectations of $68.36 million. The company's revenue was up 4.1% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.07 EPS. What other stocks do shareholders of Lumenis own? Based on aggregate information from My MarketBeat watchlists, some companies that other Lumenis investors own include Supernus Pharmaceuticals (SUPN), Aralez Pharmaceuticals (ARLZ), Omeros (OMER), Performant Financial (PFMT), Wright Medical Group (WMGI), Biocept (BIOC), Bausch Health Companies (BHC), Bioanalytical Systems (BASI), Avadel Pharmaceuticals (AVDL) and Aptevo Therapeutics (APVO). This page (NASDAQ:LMNS) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe “Perfect Storm” for GoldGold Safe ExchangeTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsBiden’s $374B Giveaway Into This SectorDTIHe Is Giving Away BitcoinCrypto Swap ProfitsThe "Smart Money" Is Ready for May 1st Are You?Stansberry ResearchThe #1 Crypto for 2024InvestorPlaceYour Money is Not SafeAmerican Alternative Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lumenis Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.